Media Coverage

The Wei and Heath labs and collaborators from MIT have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.

Sui Huang challenges the prevailing view of cancer as purely genetic. Huang and colleagues argue that many cancers lack identifiable driver mutations, suggesting non-genetic factors and disrupted gene regulatory networks may play crucial roles in cancer development.

Christian Diener, Sean Gibbons and colleagues developed a method to detect and measure food-derived DNA in human stool samples – an approach that can be used to estimate a person’s dietary intake.

Sean Gibbons was interviewed for a news story on the lack of microbial diversity onboard the International Space Station and how it might be linked to health issues.

Sean Gibbons spoke with podcast host Ira Pastor about the Gibbons Lab’s recent work decoding diet from stool DNA, and many other projects Sean has studied and taken part of over the past several years.

Sean Gibbons was interviewed and discussed the ideal bowel movement frequency and his 2024 study that looked at participants’ pooping habits and their effects on their gut microbiome and overall health.

ISB’s Gibbons Lab developed a breakthrough method that analyzes food-derived DNA in fecal metagenomes, allowing for data-driven diet tracking without the need for burdensome questionnaires.

ISB’s Heath Lab discovered key insights into how T cells – the body’s frontline immune soldiers – respond to infections like COVID-19.